美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Valion Bio Inc

0.8800

-0.0509-5.47%

盘后：0.89000.0100+1.14%19:59 EDT

成交量：36.86万

成交额：35.30万

市值：276.24万

市盈率：-0.11

高：1.06

开：0.9700

低：0.8546

收：0.9309

52周最高：5.60

52周最低：0.7217

股本：313.91万

流通股本：277.73万

量比：2.01

换手率：13.27%

股息：- -

股息率：- -

每股收益(TTM):-7.6830

每股收益(LYR):-19.6785

净资产收益率：-82.69%

总资产收益率：-28.69%

市净率：0.16

市盈率(LYR):-0.04

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

Valion Bio获美国国家过敏和传染病研究所首项FDA先例研究方案用于Entolimod™；联邦机构将全额资助BLA启动物体内研究计划并共同推进FDA申报

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/VBIO"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VBIO\",,,,,undefined,":{"symbol":"VBIO","market":"US","secType":"STK","nameCN":"Valion Bio Inc","latestPrice":0.88,"timestamp":1778875200000,"preClose":0.9309,"halted":0,"volume":368568,"hourTrading":{"tag":"盘后","latestPrice":0.89,"preClose":0.88,"latestTime":"19:59 EDT","volume":1869,"amount":1680.1068,"timestamp":1778889587805,"change":0.01,"changeRate":0.011364,"amplitude":0.051136},"delay":0,"changeRate":-0.054678268342464226,"floatShares":2777300,"shares":3139095,"eps":-7.683047,"marketStatus":"休市中","change":-0.0509,"latestTime":"05-15 16:00:00 EDT","open":0.97,"high":1.06,"low":0.8546,"amount":353034.4067856,"amplitude":0.220647,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.683047,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1779091200000},"marketStatusCode":7,"adr":0,"listingDate":1636606800000,"exchange":"NASDAQ","adjPreClose":0.9309,"preHourTrading":{"tag":"盘前","latestPrice":0.959,"preClose":0.9309,"latestTime":"09:20 EDT","volume":8956,"amount":8278.973866799999,"timestamp":1778851217872,"change":0.0281,"changeRate":0.030186,"amplitude":0.075196},"postHourTrading":{"tag":"盘后","latestPrice":0.89,"preClose":0.88,"latestTime":"19:59 EDT","volume":1869,"amount":1680.1068,"timestamp":1778889587805,"change":0.01,"changeRate":0.011364,"amplitude":0.051136},"volumeRatio":2.009379269875749},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VBIO\",,,,,undefined,":{"symbol":"VBIO","floatShares":2777300,"roa":"-28.69%","roe":"-82.69%","lyrEps":-19.678463,"volumeRatio":2.009379269875749,"shares":3139095,"dividePrice":0,"high":1.06,"amplitude":0.220647,"preClose":0.9309,"low":0.8546,"week52Low":0.721683,"pbRate":"0.16","week52High":5.6,"institutionHeld":0,"latestPrice":0.88,"eps":-7.683047,"divideRate":0,"volume":368568,"delay":0,"ttmEps":-7.683047,"open":0.97,"prevYearClose":1.45,"prevWeekClose":0.96,"prevMonthClose":0.9798,"prevQuarterClose":0.8858,"fiveDayClose":0.96,"twentyDayClose":1.26,"sixtyDayClose":0.8153},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VBIO\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VBIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VBIO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VBIO","date":"2026-05-15","current":-0.114538,"percent":0.636364,"low":-0.392475,"twenty":-0.341701,"median":-0.33551,"eighty":-0.327405,"high":-0.298231,"avg":-0.338856,"sd":0.026132,"marketCap":2922183},"quantilePoints":[{"date":"2026-04-30","current":-0.311197,"twenty":-0.324163,"median":-0.319301,"eighty":-0.314439,"marketCap":2762808},{"date":"2026-05-08","current":-0.33713,"twenty":-0.336482,"median":-0.327405,"eighty":-0.314439,"marketCap":2993043},{"date":"2026-05-15","current":-0.329149,"twenty":-0.341701,"median":-0.33551,"eighty":-0.327405,"marketCap":2922183}],"updateTime":1778975663202},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VBIO\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1120053939","title":"Valion Bio获美国国家过敏和传染病研究所首项FDA先例研究方案 用于Entolimod™；联邦机构将全额资助BLA启动物体内研究计划并共同推进FDA申报","url":"https://stock-news.laohu8.com/highlight/detail?id=1120053939","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120053939?lang=zh_cn&edition=fundamental","pubTime":"2026-05-05 20:01","pubTimestamp":1777982492,"startTime":"0","endTime":"0","summary":"Valion Bio公司宣布，已从美国国家过敏和传染病研究所获得针对Entolimod™的首个FDA先例研究方案。这一重要进展标志着联邦机构将全面资助该公司开展生物制品许可申请相关的动物体内研究项目，并将协同推进FDA申报流程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VBIO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/VBIO\",params:#limit:6,delay:false,,,undefined,":[]}}